Event calendar
-
Apr 24, 2013 - First quarter 2013 results
-
Apr 04, 2013 - Kepler Swiss Seminar
Zürich, Switzerland
-
Mar 26, 2013 - Exane Healthcare Conference
Paris, France
-
Mar 05, 2013 - Credit Suisse Healthcare Conference
London, UK
-
Feb 25, 2013 - Citi Global Healthcare Conference
New York, USA
-
Feb 22, 2013 - Annual General Meeting
St Jakobshalle, Basel, Switzerland
Notice of Annual General Meeting
Important information regarding submission of an item for the agenda
Media release
Minutes of the Annual General Meeting (0.1 MB - German)
Visit the Annual General Meeting section
-
Feb 14, 2013 - Leerink Swann Healthcare Conference
-
Feb 06, 2013 - UBS Investor Day
Dublin, Ireland
- Jan 23, 2013 - Fourth quarter and full year results 2012
-
Jan 07, 2013 - J.P. Morgan Healthcare Conference
-
Dec 11, 2012 - Nomura European Conference, Tokyo
Tokyo, Japan
-
Dec 06, 2012 - Berenberg European Conference
Pennyhill Park, UK
-
Nov 16, 2012 - Bexsero: CHMP Positive Opinion
Bexsero: A key milestone in preventing a devastating disease
-
Nov 15, 2012 - Jeffries Healthcare Conference
London, UK
-
Nov 14, 2012 - Credit Suisse Healthcare Conference
Phoenix, USA
Ameet Mallik
BU Head, Biopharmaceuticals & Oncology Injectables -
Nov 08, 2012 - Novartis R&D Investor Day
Boston, USA
Presentations
Paving our future in science-based innovation (1.0 MB)
Joseph Jimenez, CEOChanging the Practice of Medicine (3.8 MB)
Mark C. Fishman, MD, President, Novartis Institutes for BioMedical ResearchFocusing on Patients, Following the Science (2.5 MB)
Timothy M. Wright, MD, Global Head of DevelopmentOncology Translational Medicine: Bridging Science and Patients (1.8 MB)
Barbara Weber, MD, SVP and Global HeadOncology Development:
Maximizing the pipeline to deliver innovative treatments (1.2 MB)
Alessandro Riva, MD, EVP and Global Head Development, OncologyNovartis Oncology: Strategy for Growth (0.6 MB)
Herve Hoppenot, President, Novartis OncologyTurning R&D Excellence into Commercial Success (2.0 MB)
David Epstein, Division Head of Novartis Pharmaceuticals -
Oct 25, 2012 - Third quarter 2012 results
-
Sep 20, 2012 - UBS Conference
Ermatingen, Switzerland
-
Sep 11, 2012 - Bank of America Merrill Lynch Healthcare Conference
London, UK
-
Sep 10, 2012 - Morgan Stanley Healthcare Conference
-
Jul 19, 2012 - Second quarter 2012 results
-
Jun 29, 2012 - Nomura Healthcare Conference
London, UK
-
Jun 25, 2012 - JP Morgan Cazenove
Respiratory & MS Seminar
London, UK
-
Jun 25, 2012 - Credit Suisse 3rd Healthcare Workshop
Zürich, Switzerland
-
Jun 05, 2012 - Goldman Sachs 33rd Annual Global Healthcare Conference
-
May 10, 2012 - Exane Healthcare Conference
-
Apr 24, 2012 - First quarter results 2012
Basel, Switzerland
Media release
Interim financial report
-
Apr 20, 2012 - Gilenya update
-
Mar 06, 2012 - Cowen & Company 32nd Annual Healthcare Conference
-
Feb 23, 2012 - Annual General Meeting
St. Jakobshalle, Basel, Switzerland
Notice of Annual General Meeting
Media release
-
Feb 15, 2012 - Leerink Swann Bank Conference
New York, USA
Stuart Raetzman
Vice President Global Marketing, Area President US, Alcon Division - Jan 25, 2012 - Fourth quarter and full year results 2011
The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
